Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
Annexon Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH
Ticker
Exchange
SIC #
Website
Latest Ticker
ANNX
Nasdaq
8731
https://annexonbio.com/
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for Annexon Inc
Down -43.02% in 4 Weeks, Here's Why You Should You Buy the Dip in Annexon (ANNX)
- Apr 25th, 2024 1:35 pm
Are Medical Stocks Lagging Annexon (ANNX) This Year?
- Apr 17th, 2024 1:40 pm
Annexon Reports Inducement Grants to New Employees Under Nasdaq Listing Rule 5635(c)(4)
- Apr 16th, 2024 8:05 pm
Turnstone Biologics Appoints William Waddill to its Board of Directors
- Apr 16th, 2024 1:00 pm
10 Buy-Rated Stocks with Latest Insider Purchases
- Apr 14th, 2024 4:52 pm
Annexon, Inc. (ANNX) Falls More Steeply Than Broader Market: What Investors Need to Know
- Apr 10th, 2024 10:15 pm
Annexon Biosciences to Present at the 23rd Annual Needham Virtual Healthcare Conference
- Apr 3rd, 2024 12:00 pm
What Makes Annexon (ANNX) a New Buy Stock
- Apr 1st, 2024 4:00 pm
Wall Street Analysts Believe Annexon (ANNX) Could Rally 101.12%: Here's is How to Trade
- Apr 1st, 2024 1:55 pm
Annexon Inc (ANNX) Reports Year-End Financials, Aligns with Analyst Projections
- Mar 28th, 2024 9:31 am
Annexon Reports Fourth Quarter and Year-End 2023 Financial Results and Key Anticipated Milestones
- Mar 26th, 2024 8:05 pm
Annexon Reports Inducement Grant to New Employee Under Nasdaq Listing Rule 5635(c)(4)
- Mar 18th, 2024 8:05 pm
Why Annexon (ANNX) Might Surprise This Earnings Season
- Mar 14th, 2024 12:40 pm
J.P. Morgan Predicts up to 140% Rally for These 2 ‘Strong Buy’ Stocks
- Mar 12th, 2024 6:51 pm
Annexon Biosciences to Present at the TD Cowen 44th Annual Health Care Conference
- Feb 27th, 2024 1:00 pm
Annexon to Host Virtual R&D Day on Guillain-Barré Syndrome, Focusing on its Serious Unmet Need and Annexon’s Novel Therapeutic Approach
- Feb 21st, 2024 1:00 pm
Steven Cohen's Point72 Asset Management Acquires New Stake in Annexon Inc
- Feb 13th, 2024 6:10 pm
Recent uptick might appease Annexon, Inc. (NASDAQ:ANNX) institutional owners after losing 18% over the past year
- Feb 10th, 2024 12:08 pm
Take the Zacks Approach to Beat the Market: Annexon, NVIDIA, Intuit in Focus
- Jan 22nd, 2024 11:58 am
Is Annexon (ANNX) Stock Outpacing Its Medical Peers This Year?
- Jan 18th, 2024 2:40 pm
Scroll